Dynorphin A toxicity in striatal neurons via an α-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor mechanism

Neuroscience

Volumn 116, Issue 3, 2003, Pages 807-816

  Goody, R J ^a   Martin, K M ^a   Goebel, S M ^a   Hauser, K F ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Ampakine; Dizocilpine; N methyl D aspartate receptor complex; Neuroprotection; Neurotoxicology; Striatal neurons; amino 3 hydroxy 5 methylisoxazole 4 propionate receptor complex; opioid receptors

Indexed keywords

1 (1,4 BENZODIOXAN 6 YLCARBONYL)PIPERIDINE; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; AMPA RECEPTOR; DIZOCILPINE; DYNORPHIN A; GLUTAMIC ACID; KAINIC ACID RECEPTOR; KAPPA OPIATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NALOXONE; PIPERIDINE DERIVATIVE; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL ISOLATION; CELL LOSS; CELL SURVIVAL; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; EMBRYO; IMMUNOREACTIVITY; IN VITRO STUDY; MOUSE; NEUROTOXICITY; NONHUMAN; PATHOPHYSIOLOGY; PHOTOGRAPHY; PRIORITY JOURNAL; SPINAL CORD NERVE CELL;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CORPUS STRIATUM; DYNORPHINS; FEMALE; MICE; MICE, INBRED ICR; NEURONS; PREGNANCY; RECEPTORS, AMPA; RECEPTORS, KAINIC ACID;

EID: 0037450495     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00563-8     Document Type: Article

References (55)

1. Arai A., Kessler M., Rogers G., Lynch G. Effects of a memory-enhancing drug on DL-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor currents and synaptic transmission in hippocampus. J Pharmacol Exp Ther. 278:1996;627-638.
2. Bardoul M., Drian M.J., Konig N. AMPA/kainate receptors modulate the survival in vitro of embryonic brainstem cells. Int J Dev Neurosci. 15:1997;695-701.
3. Berman Y., Ageyeva L., Veksler B., Wood D., Devi L.A. Dynorphin A processing enzyme tissue distribution, isolation, and characterization. J Biochem (Tokyo). 125:1999;641-647.
4. Berman Y., Mzhavia N., Polonskaia A., Furuta M., Steiner D.F., Pintar J.E., Devi L.A. Defective prodynorphin processing in mice lacking prohormone convertase PC2. J Neurochem. 75:2000;1763-1770.
5. Bohn L.M., Belcheva M.M., Coscia C.J. Mitogenic signaling via endogenous kappa-opioid receptors in C6 glioma cells evidence for the involvement of protein kinase C and the mitogen-activated protein kinase signaling cascade. J Neurochem. 74:2000;564-573.
6. Brorson J.R., Zhang Z., Vandenberghe W. Ca(2+) permeation of AMPA receptors in cerebellar neurons expressing glu receptor 2. J Neurosci. 19:1999;9149-9159.
7. Caudle R.M., Dubner R. Ifenprodil blocks the excitatory effects of the opioid peptide dynorphin 1-17 on NMDA receptor-mediated currents in the CA3 region of the guinea pig hippocampus. Neuropeptides. 32:1998;87-95.
8. Caudle R.M., Isaac L. A novel interaction between dynorphin(1-13) and an N-methyl-D-aspartate site. Brain Res. 443:1988;329-332.
9. Caudle R.M., Mannes A.J. Dynorphin friend or foe? Pain. 87:2000;235-239.
10. Chen L., Gu Y., Huang L.Y. The mechanism of action for the block of NMDA receptor channels by the opioid peptide dynorphin. J Neurosci. 15:1995;4602-4611.
11. Chen L., Gu Y., Huang L.Y. The opioid peptide dynorphin directly blocks NMDA receptor channels in the rat. J Physiol. 482:1995;575-581.
12. Chen L., Huang L.Y. Protein kinase C reduces Mg2+ block of NMDA-receptor channels as a mechanism of modulation. Nature. 356:1992;521-523.
13. Chen Q., Harris C., Brown C.S., Howe A., Surmeier D.J., Reiner A. Glutamate-mediated excitotoxic death of cultured striatal neurons is mediated by non-NMDA receptors. Exp Neurol. 136:1995;212-224.
14. Civelli O., Douglass J., Goldstein A., Herbert E. Sequence and expression of the rat prodynorphin gene. Proc Natl Acad Sci U S A. 82:1985;4291-4295.
15. Day R., Lazure C., Basak A., Boudreault A., Limperis P., Dong W., Lindberg I. Prodynorphin processing by proprotein convertase 2. Cleavage at single basic residues and enhanced processing in the presence of carboxypeptidase activity. J Biol Chem. 273:1998;829-836.
16. Drian M., Bardoul M., Konig N. Blockade of AMPA/kainate receptors can either decrease or increase the survival of cultured neocortical cells depending on the stage of maturation. Neurochem Int. 38:2001;509-517.
17. Dubner R., Ruda M.A. Activity-dependent neuronal plasticity following tissue injury and inflammation. Trends Neurosci. 15:1992;96-103.
18. Faden A.I. Experimental neurobiology of central nervous system trauma. Crit Rev Neurobiol. 7:1993;175-186.
19. Faden A.I., Salzman S. Pharmacological strategies in CNS trauma. Trends Pharmacol Sci. 13:1992;29-35.
20. Gannon R.L., Terrian D.M. Kappa opioid agonists inhibit transmitter release from guinea pig hippocampal mossy fiber synaptosomes. Neurochem Res. 17:1992;741-747.
21. Garthwaite J., Boulton C.L. Nitric oxide signaling in the central nervous system. Ann Rev Physiol. 57:1995;683-706.
22. Han J.S., Xie C.W. Dynorphin potent analgesic effect in spinal cord of the rat. Sci Sin [B]. 27:1984;169-177.
23. Hauser K.F., Foldes J.K., Turbek C.S. Dynorphin A (1-13) neurotoxicity in vitro opioid and non-opioid mechanisms in mouse spinal cord neurons. Exp Neurol. 160:1999;361-375.
24. Hauser K.F., Knapp P.E., Turbek C.S. Structure-activity analysis of dynorphin A toxicity in spinal cord neurons intrinsic neurotoxicity of dynorphin A and its carboxyl-terminal, nonopioid metabolites. Exp Neurol. 168:2001;78-87.
25. Hauser K.F., Toran-Allerand C.D. Androgen increases the number of cells in fetal mouse spinal cord cultures implications for motoneuron survival. Brain Res. 485:1989;157-164.
26. Herman B.H., Goldstein A. Antinociception and paralysis induced by intrathecal dynorphine A. J Pharmacol Exp Ther. 232:1985;27-32.
27. Hu W.H., Lee F.C., Wan X.S., Chen Y.T., Jen M.F. Dynorphin neurotoxicity induced nitric oxide synthase expression in ventral horn cells of rat spinal cord. Neurosci Lett. 203:1996;13-16.
28. Hu W.H., Li F., Qiang W.A., Liu N., Wang G.Q., Xia J., Liu J.S., Liao W.H., Jen M.F. Dual role for nitric oxide in dynorphin spinal neurotoxicity. J Neurotrauma. 16:1999;85-98.
29. Jensen J.B., Lund T.M., Timmermann D.B., Schousboe A., Pickering D.S. Role of GluR2 expression in AMPA-induced toxicity in cultured murine cerebral cortical neurons. J Neurosci Res. 65:2001;267-277.
30. Kim M.S., Cheong Y.P., So H.S., Lee K.M., Kim T.Y., Oh J., Chung Y.T., Son Y., Kim B.R., Park R. Protective effects of morphine in peroxynitrite-induced apoptosis of primary rat neonatal astrocytes potential involvement of G protein and phosphatidylinositol 3-kinase (PI3 kinase). Biochem Pharmacol. 61:2001;779-786.
31. Kolaj M., Cerne R., Randic M. The opioid peptide dynorphin modulates AMPA and kainate responses in acutely isolated neurons from the dorsal horn. Brain Res. 671:1995;227-244.
32. Kovacs A.D., Cebers G., Cebere A., Moreira T., Liljequist S. Cortical and striatal neuronal cultures of the same embryonic origin show intrinsic differences in glutamate receptor expression and vulnerability to excitotoxicity. Exp Neurol. 168:2001;47-62.
33. Laughlin T.M., Vanderah T.W., Lashbrook J., Nichols M.L., Ossipov M., Porreca F., Wilcox G.L. Spinally administered dynorphin A produces long-lasting allodynia involvement of NMDA but not opioid receptors. Pain. 72:1997;253-260.
34. Long J.B., Rigamonti D.D., Oleshansky M.A., Wingfield C.P., Martinez-Arizala A. Dynorphin A-induced rat spinal cord injury evidence for excitatory amino acid involvement in a pharmacological model of ischemic spinal cord injury. J Pharmacol Exp Ther. 269:1994;358-366.
35. Lyeth B.G., Hayes R.L. Cholinergic and opioid mediation of traumatic brain injury. J Neurotrauma. 9:1992;S463-474.
36. Martin L.J., Furuta A., Blackstone C.D. AMPA receptor protein in developing rat brain glutamate receptor-1 expression and localization change at regional, cellular, and subcellular levels with maturation. Neuroscience. 83:1998;917-928.
37. Mattson M.P., Barger S.W., Begley J.G., Mark R.J. Calcium, free radicals, and excitotoxic neuronal death in primary cell culture. Methods Cell Biol. 46:1995;187-216.
38. McIntosh T.K., Fernyak S., Yamakami I., Faden A.I. Central and systemic kappa-opioid agonists exacerbate neurobehavioral response to brain injury in rats. Am J Physiol. 267:1994;R665-672.
39. McIntosh T.K., Head V.A., Faden A.I. Alterations in regional concentrations of endogenous opioids following traumatic brain injury in the cat. Brain Res. 425:1987;225-233.
40. Montoliu C., Llansola M., Kosenko E., Corbalan R., Felipo V. Role of cyclic GMP in glutamate neurotoxicity in primary cultures of cerebellar neurons. Neuropharmacology. 38:1999;1883-1891.
41. Nagarajan N., Quast C., Boxall A.R., Shahid M., Rosenmund C. Mechanism and impact of allosteric AMPA receptor modulation by the ampakine CX546. Neuropharmacology. 41:2001;650-663.
42. Nakazawa T., Ikeda M., Kaneko T., Yamatsu K. Analgesic effects of dynorphin-A and morphine in mice. Peptides. 6:1985;75-78.
43. Nansen E.A., Jokel E.S., Lobo M.K., Micevych P.E., Ariano M.A., Levine M.S. Striatal ionotropic glutamate receptor ontogeny in the rat. Dev Neurosci. 22:2000;329-340.
44. Polakiewicz R.D., Schieferl S.M., Gingras A.C., Sonenberg N., Comb M.J. mu-Opioid receptor activates signaling pathways implicated in cell survival and translational control. J Biol Chem. 273:1998;23534-23541.
45. Porreca F., Filla A., Burks T.F. Studies in vivo with dynorphin-(1-9) analgesia but not gastrointestinal effects following intrathecal administration to mice. Eur J Pharmacol. 91:1983;291-294.
46. Shukla V.K., Lemaire S. Central non-opioid physiological and pathophysiological effects of dynorphin A and related peptides. J Psychiatry Neurosci. 17:1992;106-119.
47. Shukla V.K., Lemaire S. Non-opioid effects of dynorphins possible role of the NMDA receptor. Trends Pharmacol Sci. 15:1994;420-424.
48. Snyder S.H., Jaffrey S.R., Zakhary R. Nitric oxide and carbon monoxide parallel roles as neural messengers. Brain Res Rev. 26:1998;167-175.
49. Spampinato S., Candeletti S. Characterization of dynorphin A-induced antinociception at spinal level. Eur J Pharmacol. 110:1985;21-30.
50. Tang Q., Gandhoke R., Burritt A., Hruby V.J., Porreca F., Lai J. High-affinity interaction of (des-Tyrosyl)dynorphin A(2-17) with NMDA receptors. J Pharmacol Exp Ther. 291:1999;760-765.
51. Tang Q., Lynch R.M., Porreca F., Lai J. Dynorphin A elicits an increase in intracellular calcium in cultured neurons via a non-opioid, non-NMDA mechanism. J Neurophysiol. 83:2000;2610-2615.
52. Tan-No K., Cebers G., Yakovleva T., Hoon Goh B., Gileva I., Reznikov K., Aguilar-Santelises M., Hauser K.F., Terenius L., Bakalkin G. Cytotoxic effects of dynorphins through nonopioid intracellular mechanisms. Exp Cell Res. 269:2001;54-63.
53. Vanderah T.W., Laughlin T., Lashbrook J.M., Nichols M.L., Wilcox G.L., Ossipov M.H., Malan T.P. Jr, Porreca F. Single intrathecal injections of dynorphin A or des-Tyr-dynorphins produce long-lasting allodynia in rats blockade by MK-801 but not naloxone. Pain. 68:1996;275-281.
54. Xue J.C., Yu Y.X., Han J.S., Jen M.F. Comparative study of the analgesic and paralytic effects induced by intrathecal dynorphin a in rats. Int J Neurosci. 82:1995;83-93.
55. Zheng M., Streck R.D., Scott R.E., Seidah N.G., Pintar J.E. The developmental expression in rat of proteases furin, PC1, PC2, and carboxypeptidase E implications for early maturation of proteolytic processing capacity. J Neurosci. 14:1994;4656-4673.